Jamal El-Mosleh
Chief Executive Officer at ELICERA THERAPEUTICS AB
Profile
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB.
Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB.
He also served on the board at Elypta AB.
He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Jamal El-Mosleh active positions
| Companies | Position | Start |
|---|---|---|
| ELICERA THERAPEUTICS AB | Chief Executive Officer | 2019-12-31 |
Former positions of Jamal El-Mosleh
| Companies | Position | End |
|---|---|---|
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Director/Board Member | 2019-12-31 |
| ANNEXIN PHARMACEUTICALS AB | Chief Executive Officer | 2018-12-31 |
| MENDUS AB | Chief Executive Officer | 2016-09-30 |
Training of Jamal El-Mosleh
| Chalmers University of Technology | Graduate Degree |
| Chalmers School of Entrepreneurship | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MENDUS AB | Health Technology |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Private companies | 1 |
|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Technology Services |
- Stock Market
- Insiders
- Jamal El-Mosleh
